000119790 001__ 119790
000119790 005__ 20240207145454.0
000119790 0247_ $$2doi$$a10.1177/09645284211055750
000119790 0248_ $$2sideral$$a127311
000119790 037__ $$aART-2021-127311
000119790 041__ $$aeng
000119790 100__ $$aFernández Sanchis, D.
000119790 245__ $$aCost-effectiveness of upper extremity dry needling in the rehabilitation of patients with stroke
000119790 260__ $$c2021
000119790 5060_ $$aAccess copy available to the general public$$fUnrestricted
000119790 5203_ $$aIntroduction: Dry needling (DN) has been shown to be effective for the treatment of upper extremity hypertonia in patients with stroke. Purpose: To evaluate the cost-effectiveness of DN in patients with stroke. Methods: A cost-effectiveness analysis was performed in a research study conducted at a Spanish public hospital where patients were classified into two groups with or without DN. Hypertonia was measured using the Modified Modified Ashworth Scale (MMAS), and quality of life (QOL) was assessed using the EuroQoL 5-dimension questionnaire. Data regarding the effects and costs of physiotherapy were presented by calculating the mean and 95% confidence interval. The health outcomes were evaluated considering the rate of responders to the treatment based on the MMAS. Spanish preference weights were used to estimate quality-adjusted life years (QALYs). The incremental cost-effectiveness ratio (ICER) and incremental cost-utility ratio (ICUR) were calculated to determine the economic value of DN. Results: Eighty patients with stroke in the subacute stage of recovery were selected to participate in this study. Based on the rate of responders, the ICER of the DN group was very low. Despite the sensitivity analysis performed, the results of the ICUR were not encouraging. Discussion: Cost-effectiveness with responder rate results were favourable for the DN group and were confirmed by the sensitivity analysis according to levels of care. In addition, our findings revealed that 4 weeks of treatment could be more cost-effective than 8 weeks. DN treatment of the upper extremity appears to be cost-effective based on the rate of responders measured using the MMAS scale. © The Author(s) 2021.
000119790 540__ $$9info:eu-repo/semantics/openAccess$$aAll rights reserved$$uhttp://www.europeana.eu/rights/rr-f/
000119790 590__ $$a1.976$$b2021
000119790 591__ $$aINTEGRATIVE & COMPLEMENTARY MEDICINE$$b22 / 30 = 0.733$$c2021$$dQ3$$eT3
000119790 592__ $$a0.409$$b2021
000119790 593__ $$aMedicine (miscellaneous)$$c2021$$dQ2
000119790 593__ $$aComplementary and Alternative Medicine$$c2021$$dQ2
000119790 594__ $$a3.1$$b2021
000119790 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/submittedVersion
000119790 700__ $$aCuenca Zaldívar, J.N.
000119790 700__ $$0(orcid)0000-0002-1674-7788$$aCalvo, S.$$uUniversidad de Zaragoza
000119790 700__ $$0(orcid)0000-0002-9201-0120$$aHerrero, P.$$uUniversidad de Zaragoza
000119790 700__ $$aGómez Barrera, M.
000119790 7102_ $$11006$$2413$$aUniversidad de Zaragoza$$bDpto. Fisiatría y Enfermería$$cÁrea Fisioterapia
000119790 773__ $$g40, 2 (2021), 160-168$$pACUPUNCTURE IN MEDICINE$$tAcupuncture in Medicine$$x0964-5284
000119790 8564_ $$s339093$$uhttps://zaguan.unizar.es/record/119790/files/texto_completo.pdf$$yPreprint
000119790 8564_ $$s864707$$uhttps://zaguan.unizar.es/record/119790/files/texto_completo.jpg?subformat=icon$$xicon$$yPreprint
000119790 909CO $$ooai:zaguan.unizar.es:119790$$particulos$$pdriver
000119790 951__ $$a2024-02-07-14:52:21
000119790 980__ $$aARTICLE